Gerresheimer: Groundbreaking ceremony for plant expansion in Querétaro, Mexico

Investment volume of around 100 million Euros

13-Nov-2023 - Gerresheimer has celebrated the start of construction of the plant expansion at its facility in Querétaro, Mexico, with a ground-breaking ceremony. Thanks to the new 7,500 m² production building, Gerresheimer will increase its manufacturing capacity for syringes for the North American market by ...

Gerresheimer invests up to 94 million Dollar in US production facility

Major expansion in the North American market

16-Aug-2022 - Gerresheimer AG announced investments to rapidly expand its manufacturing, supply and logistics capability for glass vials in the U.S. The project will be supported by the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for ...

Gerresheimer partners with MedTech start-up Adamant Health to revolutionize treatment of Parkinson’s disease

Gerresheimer participates in seed-round of the Finnish MedTech company and university spin-off

15-Jun-2022 - Gerresheimer AG and the Finnish start-up Adamant Health Oy partner up to develop a life-changing solution for millions of people worldwide suffering from Parkinson’s disease. The measuring technology and platform in development will address one of the biggest impediments in treating symptoms of ...

Dietmar Siemssen appointed new CEO of Gerresheimer

Speaker of the Management Board and CFO Rainer Beaujean will not extend contract

07-Sep-2018 - Dietmar Siemssen (55) will join the Management Board of Gerresheimer AG as Chief Executive Officer on November 1, 2018. The Supervisory Board of Gerresheimer AG approved the decision in its meeting. From 2011 to July 2018, Dietmar Siemssen was CEO of Stabilus and prior to that served for 19 years ...

Gerresheimer expands production of pharmaceutical plastic packaging in Brazil

23-May-2018 - Gerresheimer, the leading manufacturer of specialist packaging for drugs, is further expanding its strong presence on the South American market. The new Gerresheimer Anápolis plant has commenced production in the Brazilian state of Goiás in order to secure and support the continued strong ...

Gerresheimer - New CEO

Dr. Christian Fischer to succeed Uwe Röhrhoff

01-Sep-2017 - With effect from September 1, 2017, Dr. Christian Fischer (53) is to assume responsibility as Chief Executive Officer of Gerresheimer AG. He succeeds Uwe Röhrhoff (55), who is leaving the company as of August 31, 2017. Christian Fischer joined the Management Board as a regular member on August 1, ...

Gerresheimer modernizing its Pfreimd site

Company switching to a more powerful, more energy-efficient technology

15-Mar-2017 - Gerresheimer is sparing little expense in bringing cutting-edge technology to the buildings at its German production site in Pfreimd. The first phase of the construction process – renovating the whole of the clean room in Hall 2 – has just been completed, with Halls 1 and 3 to follow. This switch ...

Dr. Christian Fischer to be appointed CEO of Gerresheimer AG

06-Mar-2017 - Dr. Christian Fischer (53) will join the Management Board of Gerresheimer AG as an ordinary member on August 1, 2017 before taking over as Chief Executive Officer on September 1, 2017. Dr. Christian Fischer is currently President, Performance Chemicals, at BASF SE in Ludwigshafen, Germany. Uwe ...

Gerresheimer to sell Life Science research business

12-Sep-2016 - Gerresheimer and Chase Scientific Glass, Inc. are to sell their joint venture (51/49%) Kimble Chase to Duran Group, a portfolio company of One Equity Partners - Total transaction enterprise value of USD 131m for 100% of the business. In line with its strategy of focusing on packaging and device ...

Gerresheimer: Substantially increases earnings in second quarter

Adjusted earnings per share surpass prior-year quarter by 34.5%

11-Jul-2016 - Gerresheimer AG, a partner to the pharma and healthcare industry worldwide, performed in accordance with expectations in the second quarter of 2016. “We completed this last quarter with very good results. All key earnings indicators show double-digit growth and the revenue trend is in line with ...